C-Peptide: A Mediator of the Association Between Serum Uric Acid to Creatinine Ratio and Non-Alcoholic Fatty Liver Disease in a Chinese Population With Normal Serum Uric Acid Levels

被引:15
|
作者
Ma, Chifa [1 ]
Liu, Yiwen [1 ]
He, Shuli [2 ]
Zeng, Jingbo [3 ]
Li, Pingping [4 ,5 ]
Ma, Chunxiao [4 ,5 ]
Ping, Fan [1 ]
Zhang, Huabing [1 ]
Xu, Lingling [1 ]
Li, Wei [1 ]
Li, Yuxiu [1 ]
机构
[1] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Peking Union Med Coll, Dept Endocrinol,Key Lab Endocrinol,Minist Hlth, Beijing, Peoples R China
[2] Peking Union Med Coll Hosp, Dept Nutr, Beijing, Peoples R China
[3] Capital Med Univ, Fuxing Hosp, Clin Med Coll 8, Dept Endocrinol, Beijing, Peoples R China
[4] Chinese Acad Med Sci & Peking Union Med Coll, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing, Peoples R China
[5] Chinese Acad Med Sci, Diabet Res Ctr, Beijing, Peoples R China
来源
FRONTIERS IN ENDOCRINOLOGY | 2020年 / 11卷
关键词
C‐ peptide (blood); mediated effect; non-alcoholic fatty liver disease; normal-ranged uric acid; serum uric acid to creatinine ratio; INSULIN-RESISTANCE; CELL FUNCTION; RISK; PATHOGENESIS; DEFINITION; GENERATION; STEATOSIS; SECRETION; DIAGNOSIS; MELLITUS;
D O I
10.3389/fendo.2020.600472
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The data on the relationship between normal-ranged serum uric acid (SUA), beta-cell function, and non-alcoholic fatty liver disease (NAFLD) are complicated and insufficient. Moreover, uric acid is excreted by kidney, and SUA levels may be affected by renal function. Thus, we introduced a renal function-normalized index [serum uric acid to creatinine ratio (SUA/Cr)] into the study and explored the association between SUA/Cr, C-peptide and NAFLD in a Chinese population with normal SUA levels by a cross-sectional analysis. Materials and Methods A total of 282 individuals with normal SUA levels and different glucose tolerance status from a diabetes project were included in the study (mean age = 53.7 +/- 10.5 years; women = 64.50%). NAFLD was diagnosed by abdominal ultrasonography (NAFLD, n=86; without NAFLD, n=196). Trapezoid formula was used to calculate area under the curve of C-peptide (AUC(CP)) from 4 points (including 0, 30,60, and 120min) during 2-h oral glucose tolerance test. Spearman correlation analysis was used to explore the correlation between SUA/Cr, AUC(CP) and NAFLD risk factors. Multiple logistic regression analysis was used to explore the association between SUA/Cr or AUC(CP) and NAFLD. Mediation analysis was used to explore whether AUC(CP) mediated the association between SUA/Cr and NAFLD. Results Individuals with NAFLD had significantly higher SUA/Cr and AUC(CP) than those without NAFLD(P<0.05). Spearman correlation analysis showed that both SUA/Cr and AUC(CP) were significantly associated with many NAFLD risk factors, and SUA/Cr was positively correlated with AUC(CP) (P<0.05). Multiple logistic regression analysis indicated that SUA/Cr and AUC(CP) were positively associated with NAFLD incidence (P<0.05). Medication analysis indicated that SUA/Cr had a significant direct effect on NAFLD (beta =0.5854, 95% CI: 0.3232-0.8966), and AUC(CP) partly mediated the indirect effect of SUA/Cr on NAFLD incidence (beta =0.1311, 95% CI: 0.0168-0.4663). Conclusions SUA/Cr was positively associated with NAFLD incidence, and AUC(CP) partly mediated the association in a Chinese population with normal SUA levels. Thus, we should pay more attention to high-normal SUA and C-peptide levels due to their predictive power in NAFLD incidence.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Association between serum uric acid and non-alcoholic fatty liver disease in Korean adults
    Lee, Yong-Jae
    Lee, Hye-Ree
    Lee, Jung-Hyun
    Shin, Youn-Ho
    Shim, Jae-Yong
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2010, 48 (02) : 175 - 180
  • [2] Association between serum uric acid level and non-alcoholic fatty liver disease in Koreans
    Park, Huiyul
    Park, Kye-Yeung
    Kim, Minki
    Park, Hoon-Ki
    Hwang, Hwan-Sik
    ASIAN BIOMEDICINE, 2022, 16 (01) : 15 - 22
  • [3] The relationship of serum uric acid with non-alcoholic fatty liver disease
    Sertoglu, Erdim
    Ercin, Cemal Nuri
    Celebi, Gurkan
    Gurel, Hasan
    Kayadibi, Huseyin
    Genc, Halil
    Kara, Muammer
    Dogru, Teoman
    CLINICAL BIOCHEMISTRY, 2014, 47 (06) : 383 - 388
  • [4] Serum uric acid and non-alcoholic fatty liver disease in non-obesity Chinese adults
    Zheng, Xiaoya
    Gong, Lilin
    Luo, Rong
    Chen, Hua
    Peng, Bin
    Ren, Wei
    Wang, Yonghong
    LIPIDS IN HEALTH AND DISEASE, 2017, 16
  • [5] Association between serum ferritin and uric acid levels and nonalcoholic fatty liver disease in the Chinese population
    Zhou, Fangli
    He, Xiaoli
    Liu, Dan
    Ye, Yan
    Tian, Haoming
    Tian, Li
    PEERJ, 2023, 11
  • [6] Serum uric acid levels and prognosis of patients with non-alcoholic fatty liver disease
    Yang, Xinyi
    Lin, Yan
    Huang, Jiaofeng
    Chi, Yujing
    Wu, Yinlian
    Lin, Su
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [7] Evaluation of Serum Uric Acid as a Marker of Non-Alcoholic Fatty Liver Disease
    Rehman, Sadia
    Mehboob, Fatima
    Anjum, Nargis
    Salahuddin, Huma
    Kumar, Winay
    Wasi, Nosheen
    ANNALS ABBASI SHAHEED HOSPITAL & KARACHI MEDICAL & DENTAL COLLEGE, 2020, 25 (01): : 10 - 15
  • [8] Associations between Serum Uric Acid and the Remission of Non-Alcoholic Fatty Liver Disease in Chinese Males
    Zhou, Zhiwei
    Song, Kai
    Qiu, Jing
    Wang, Yiying
    Liu, Chunxing
    Zhou, Hui
    Xu, Yunfang
    Guo, Zhirong
    Zhang, Biao
    Dong, Chen
    PLOS ONE, 2016, 11 (11):
  • [9] Cross-sectional study on the association between serum uric acid levels and non-alcoholic fatty liver disease in an elderly population
    Xu, Jianqing
    Deng, Ming
    Weng, Yinghui
    Feng, Hui
    He, Xuelian
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [10] The serum uric acid/creatinine ratio is associated with nonalcoholic fatty liver disease in the general population
    Sookoian, Silvia
    Pirola, Carlos J.
    JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY, 2023, 79 (04) : 891 - 899